Cvs Health (CVS) Price to Sales (2009 - 2026)

Cvs Health (CVS) has reported Price to Sales for 18 consecutive years, with 1.25 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales rose 41.03% year-over-year to 1.25; the trailing twelve-month figure through Jun 2026 stood at 0.32 (up 40.91% YoY), and the FY2025 full-year result was 0.25, up 65.35% from the prior year.
• Price to Sales advanced to 1.25 in Q2 2026 per CVS's latest filing, from 0.91 in the prior quarter.
• Across five years, Price to Sales topped out at 1.72 in Q1 2022 and bottomed at 0.58 in Q4 2024.
• Historically, Price to Sales has averaged 1.09 across 5 years, with a median of 1.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Price to Sales sank 46.6% in 2024, then soared 64.86% in 2025.
• Over 5 years, Price to Sales stood at 1.44 in 2022, then retreated by 24.97% to 1.08 in 2023, then tumbled by 46.6% to 0.58 in 2024, then surged by 64.86% to 0.95 in 2025, then soared by 30.58% to 1.25 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 1.25, 0.91, and 0.95 for Q2 2026, Q1 2026, and Q4 2025 respectively.